(Q46415777)

22 December 2017

title

Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation (English)

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

7 December 2022

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

7 December 2022

author name string

H. G. Fieseler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

V. W. Armstrong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

E. Wieland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

J. Thiery

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

E. Schütz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

A. K. Walli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

D. Seidel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1840246

7 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1840246

7 December 2022

publication date

1 December 1991

1 reference

22 December 2017

31 December 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1840246

full work available at URL

7 December 2022

https://api.elsevier.com/content/article/PII:0009898191902399?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

https://api.elsevier.com/content/article/PII:0009898191902399?httpAccept=text/plain

7 December 2022

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

7 December 2022

1 reference

22 December 2017

volume

204

1 reference

22 December 2017

page(s)

291-300

1 reference

22 December 2017

issue

1-3

1 reference

22 December 2017

The mysteries of lipoprotein(a)

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Lipoprotein (a). Heterogeneity and biological relevance

7 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

7 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Lipoprotein(a) as a strong indicator for cerebrovascular disease

7 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia

7 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

7 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with alpha-tocopheryl nicotinate

7 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Lipoprotein(a) reduction by N-acetylcysteine

7 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

7 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Unchanged serum lipoprotein (a) concentrations with lovastatin

7 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

7 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Lovastatin, pravastatin, and serum lipoprotein(a)

7 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

7 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Raised serum lipoprotein during treatment with lovastatin

7 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Transient changes of serum lipoprotein(a) as an acute phase protein

7 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels

7 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

A new concept for quality control of clinical laboratory investigations in the light of clinical requirements and based on reference method values

7 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

7 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

Lipoprotein Lp(a) and the risk for myocardial infarction

7 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0009-8981(91)90239-9

7 December 2022

Identifiers

1 reference

22 December 2017

1 reference

22 December 2017